Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

COVID-19 symptoms range from mild to severe, with older adults at higher risk.

Certain plasma proteins and genes are linked to obstructive sleep apnea, suggesting potential new treatments.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Testosterone's effects on COVID-19 are unclear and need more research.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Androgens play a key role in causing alopecia by changing the hair growth cycle.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Age, health conditions, race, and gender affect COVID-19 risk.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Gender and social factors, not just biology, affect COVID-19 death rates.